NCT06866535 (Cohorte VIP) is a clinical trial in Aortitis, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT06866535?

NCT06866535 is sponsored by University Hospital, Bordeaux.

What condition does NCT06866535 study?

NCT06866535 studies Aortitis, Vascular Graft Infection, Blood Vessel Prosthesis, Infections.

Is NCT06866535 still recruiting?

NCT06866535 is currently recruiting now. Last updated 10 March 2025.

Last reviewed 2025-03-10 · How we verify

NCT06866535: Cohorte VIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VIP - Vascular Infection Project

Recruiting now Last updated 10 March 2025

What this trial tests

trial in Aortitis in 1,000 participants. Currently enrolling.

Timeline

10 May 2022

Primary endpoint
10 May 2032

10 May 2032

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	10 May 2022
Primary completion	10 May 2032
Estimated completion	10 May 2032
Sites	1 location across France

Conditions studied

Aortitis — all drugs for Aortitis →
Vascular Graft Infection — all drugs for Vascular Graft Infection →
Blood Vessel Prosthesis — all drugs for Blood Vessel Prosthesis →
Infections — all drugs for Infections →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Aortitis or Vascular Graft Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Constitution of a prospective multicentric observational database to study vascular infections, both native, especially aortitis, and vascular graft and endograft infections. Clinical and paraclinical data on medical, surgical, anesthetic and intensive care management will be collected in order to better characterize these infections

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortitis

Currently open trials in the same condition.

NCT06271018 — TocILizumab in aorTitis in GCA (TILT) · recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06866535 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 10 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06866535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing